Skip to content
Wenlo
Sign in
← Markets

HCA Healthcare, Inc.

Jon M Foster (EVP and COO) sells HCA shares

4HCAFiled Nov 6, 2026, 5:09 PM ET· Period Nov 4, 2026

AI-generated summary

EVP and COO Jon M Foster sold 31,713 shares of common stock for an average price of $500.98, totaling approximately $15.9M. They also exercised derivatives to acquire 35,880 shares, had 20,309 shares withheld for taxes, and transferred 16,142 shares from indirect to direct ownership. After these transactions, the insider directly holds 10,000 shares.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Jon M Foster · EVP and COO
DateTransactionSharesPriceValueHeld afterOwnership
Nov 4, 2026S · open-market saleFootnotes F1−10,000$514.07$5,140,698.000Direct
Nov 4, 2026M · exercise or conversion of a derivative+35,880$145.24$5,211,211.2035,880Direct
Nov 4, 2026F · tax withholding−20,309$510.70$10,371,806.3015,571Direct
Nov 4, 2026J · otherFootnotes F2−16,142$503.52$8,127,900.5551,453Indirect (By JMF Trust (Spouse and Robert Nagel, Co-Trustees))
Nov 6, 2026S · open-market saleFootnotes F3, F2−890$498.97$444,084.1930,823Direct
Nov 6, 2026S · open-market saleFootnotes F4−1,684$498.00$838,629.3129,139Direct
Nov 6, 2026S · open-market saleFootnotes F5−1,066$496.92$529,716.6128,073Direct
Nov 6, 2026S · open-market saleFootnotes F6−2,692$495.85$1,334,839.2425,381Direct
Nov 6, 2026S · open-market saleFootnotes F7−7,595$494.91$3,758,875.6317,786Direct
Nov 6, 2026S · open-market saleFootnotes F8−6,302$493.58$3,110,538.0111,484Direct
Nov 6, 2026S · open-market saleFootnotes F9−1,484$491.98$730,100.8410,000Direct
Nov 4, 2026M · exercise or conversion of a derivativeStock Appreciation RightFootnotes F10−35,880$0.00$0.000Direct
Footnotes
  1. F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $513.87 to $514.24, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2 Pursuant to a power of substitution, on November 4, 2026, the reporting person transferred 16,142 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $503.525 (the average of the high and low prices of shares of common stock of the Issuer on November 4, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the reporting person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the reporting person as indirectly owned. The reporting person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.
  3. F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $498.54 to $499.53, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $497.55 to $498.51, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $496.55 to $497.51, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $495.49 to $496.47, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $494.43 to $495.42, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $492.50 to $494.42, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $491.46 to $492.36, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. F10 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.

More HCA filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.